UNITED
STATES
 SECURITIES
AND EXCHANGE COMMISSION
 Washington,
D.C. 20549
 
  ________________
  FORM
10-Q
 _______________
 
  (Mark One)
  [X]                QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)
 OF
THE SECURITIES EXCHANGE ACT OF 1934
 
  For the quarterly period ended June
30, 2008
 
 or
  [   ]                TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d)
 OF THE SECURITIES EXCHANGE ACT OF
1934
 
   Commission
File Number: 0-26824
 
 TEGAL
CORPORATION
 (Exact
Name of Registrant as Specified in Its Charter)
 
 Delaware
              68-0370244(State
      or other jurisdiction of
              (I.R.S.
      Employer Identification No.)incorporation
      or organization)
 
 2201
South McDowell Blvd.
 Petaluma,
California 94954
 (Address
of Principal Executive Offices)
 
 Telephone
Number (707) 763-5600
 (Registrant’s
Telephone Number, Including Area Code)
 
  ________________
  
 Indicate
by check mark whether the registrant: (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file reports) and (2) has been subject to such filing requirements for the
past 90 days.    Yes [X]    No
[   ]
 
 Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer or a smaller reporting
company.  See definitions of “large accelerated filer”, “accelerated
filer” and “smaller reporting company” in Rule 12b-2 of the Exchange
Act.
 
 Large
Accelerated
Filer   [  ]                                                                                                                                                             
Accelerated
Filer                    [  ]
 
 Non-Accelerated
Filer     [  ] (Do not check if a smaller
reporting
company)                                                                             Smaller
reporting company  [X]
 
 
 Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes [  ]  No [X]
 
 As of August 13, 2008
therewere 7,263,473 shares of the
Registrant’s common stock outstanding.The number of shares
outstanding reflects a 1 to 12 reverse stock split effected by the Registrant on
July 25, 2006.
 
 
  
  TEGAL
CORPORATION AND SUBSIDIARIES
 
 INDEX
 
  PagePART
      I. FINANCIAL INFORMATIONItem
      1.
              Condensed
      Consolidated Financial Statements (Unaudited)Condensed
      Consolidated Balance Sheets as of June 30, 2008 and March 31,
      2008
              3Condensed
      Consolidated Statements of Operations for the three months
      ended  June 30, 2008 and June 30, 2007
              4Condensed
      Consolidated Statements of Cash Flows for the three months ended June 30,
      2007 and June 30, 2007
              5Notes
      to Condensed Consolidated Financial Statements
              6Item
      2.
              Management’s
      Discussion and Analysis of Financial Condition and Results of
      Operations
              10Item
      3.
              Quantitative
      and Qualitative Disclosures About Market Risk
              14Item
      4.
              Controls
      and Procedures
              14PART
      II. OTHER INFORMATIONItem
      1A.
              Risk
      Factors
              14Item
      6.
              Exhibits
              16Signatures
              
              17
  - 2
-
  PART
I — FINANCIAL INFORMATION
 
 Item
1. Condensed Consolidated
Financial Statements
 
 TEGAL
CORPORATION AND SUBSIDIARIES
 CONDENSED
CONSOLIDATED BALANCE SHEETS
 (Unaudited)
 (In
thousands, except share data)
 
 
 
 
 
 June 30,
              
              
              March
31,2008
              
              
              2008ASSETSCurrent
      assets:Cash
      and cash equivalents
              
              $
              18,181
              
              
              $
              19,271Accounts
      receivable, net of allowances for sales returns and doubtful accounts of
      $227 and $191 at June 30,2008 and March 31, 2008,
    respectively
              
              
              5,994
              
              
              
              6,758Inventories,
      net
              
              
              11,009
              
              
              
              11,056Prepaid
      expenses and other current assets
              
              
              794
              
              
              
              788Total
      current assets
              
              
              35,978
              
              
              
              37,873Property
      and equipment, net
              
              
              1,233
              
              
              
              1,213Intangible
      assets, net
              
              
              842
              
              
              
              903Other
      assets
              
              
              84
              
              
              
              90Total
      assets
              
              $
              38,137
              
              
              $
              40,079LIABILITIES
      AND STOCKHOLDERS’ EQUITYCurrent
      liabilities:Notes/Leases
      payable
              
              $
              8
              
              
              $
              14Accounts
      payable
              
              
              896
              
              
              
              1,469Accrued
      product warranty
              
              
              1,315
              
              
              
              1,770Deferred
      revenue
              
              
              383
              
              
              
              252Accrued
      expenses and other current liabilities
              
              
              3,067
              
              
              
              3,644Total
      current liabilities
              
              $
              5,669
              
              
              $
              7,149Commitments
      and contingencies (Note 8)Stockholders’
      equity:Preferred
      stock; $0.01 par value; 5,000,000 shares authorized; none issued and
      outstanding
              
              $
              -
              
              
              $
              -Common
      stock; $0.01 par value; 50,000,000 shares authorized; 7,263,473 and
      7,242,736
      shares issued and outstanding at June 30, 2008 and March 31, 2008,
      respectively
              
              
              73
              
              
              
              72Additional
      paid-in capital
              
              
              123,898
              
              
              
              123,567Accumulated
      other comprehensive (loss) income
              
              
              (448
              )
              
              
              (446
              )Accumulated
      deficit
              
              
              (91,055
              )
              
              
              (90,263
              )Total
      stockholders’ equity
              
              
              32,468
              
              
              
              32,930Total
      liabilities and stockholders’ equity
              
              $
              38,137
              
              
              $
              40,079
 
 See
accompanying notes to consolidated financial statements.
 
 
  - 3
-
  
 TEGAL
CORPORATION AND SUBSIDIARIES
 CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
 (Unaudited)
 (In
thousands, except per share data)
 
 
 Three
      Months Ended
                June 30,2008
              
              
              2007Revenue
              
              $
              4,729
              
              
              $
              4,598Cost
      of revenue
              
              
              2,402
              
              
              
              2,977Gross
      profit
              
              
              2,327
              
              
              
              1,621Operating
      expenses:Research
      and development expenses
              
              
              1,136
              
              
              
              778Sales
      and marketing expenses
              
              
              843
              
              
              
              1,006General
      and administrative expenses
              
              
              1,330
              
              
              
              1,203Total
      operating expenses
              
              
              3,309
              
              
              
              2,987Operating
      income (loss)
              
              
              (982
              )
              
              
              (1,366
              )Other
      income (expense), net
              
              
              190
              
              
              
              728Income
      (loss) before income tax expense (benefit)
              
              
              (792
              )
              
              
              (638
              )Net
      income (loss)
              
              $
              (792
              )
              
              $
              (638
              )Net
      income (loss) per share:Basic
              
              $
              (0.11
              )
              
              $
              (0.09
              )Diluted
              
              $
              (0.11
              )
              
              $
              (0.09
              )Weighted
      average shares used in per share computation:Basic
      and diluted
              
              
              7,177
              
              
              
              7,110
 
 
 See
accompanying notes to consolidated financial statements.
  - 4
-
  TEGAL
CORPORATION AND SUBSIDIARIES
 CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
 (Unaudited)
 (In
thousands)
 
 Three
      Months Ended
                June 30,2008
              
              
              2007Cash
      flows from operating activities:Net
      loss
              
              $
              (792
              )
              
              $
              (638
              )Adjustments
      to reconcile net loss to net cash used in operating
      activities:Depreciation
      and
      amortization
              
              
              185
              
              
              
              215Stock
      compensation
      expense
              
              
              320
              
              
              
              380Stock
      issued under stock purchase
      plan
              
              
              12
              
              
              
              8Provision
      for doubtful accounts and sales returns allowances
              
              
              36
              
              
              
              (95
              )Loss
      on disposal of property and
      equipment
              
              
              14
              
              
              
              —Fair
      value of warrants and options issued for services rendered
              
              
              —
              
              
              
              9Changes
      in operating assets and liabilities:Accounts
      receivables
              
              
              728
              
              
              
              (159
              )Inventories,
      net
              
              
              47
              
              
              
              (3,137
              )Prepaid
      expenses and other
      assets
              
              
              (1
              )
              
              
              (302
              )Accounts
      payable
              
              
              (573
              )
              
              
              1,736Accrued
      expenses and other current
      liabilities
              
              
              (577
              )
              
              
              (360
              )Accrued
      product
      warranty
              
              
              (456
              )
              
              
              114Deferred
      revenue
              
              
              130
              
              
              
              (96
              )Net
      cash used in operating
      activities
              
              
              (927
              )
              
              
              (2,325
              )Cash
      flows used in investing activities:Purchases
      of property and
      equipment
              
              
              (158
              )
              
              
              (102
              )Net
      cash used in investing
      activities:
              
              
              (158
              )
              
              
              (102
              )Cash
      flows provided by financing activities:(Repayments)
      borrowings under notes payable and bank lines of credit
              
              
              —
              
              
              
              (10
              )Payments
      on capital lease
      financing
              
              
              (5
              )
              
              
              —Net
      cash used in financing
      activities
              
              
              (5
              )
              
              
              (10
              )Effect
      of exchange rates on cash and cash
      equivalents
              
              
              —
              
              
              
              10Net
      decrease in cash and cash
      equivalents
              
              
              (1,090
              )
              
              
              (2,427
              )Cash
      and cash equivalents at beginning of
      period
              
              
              19,271
              
              
              
              25,776Cash
      and cash equivalents at end of
      period
              
              $
              18,181
              
              
              $
              23,349
 
 See
accompanying notes.
 
 
  - 5
-
  TEGAL
CORPORATION AND SUBSIDIARIES
 
 NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 (Unaudited)
 (All
amounts in thousands, except share data)
 
 1.      Basis
of Presentation:
 
 In the
opinion of management, the unaudited condensed consolidated interim financial
statements have been prepared on the same basis as the March 31, 2008 audited
consolidated financial statements and include all adjustments, consisting only
of normal recurring adjustments, necessary to fairly state the information set
forth herein.  The statements have been prepared in accordance with
the regulations of the Securities and Exchange Commission (“SEC”), but omit
certain information and footnote disclosures necessary to present the statements
in accordance with generally accepted accounting principles.  These
interim financial statements should be read in conjunction with the audited
consolidated financial statements and footnotes included in the Company’s Annual
Report on Form 10-K for the fiscal year ended March 31, 2008.  The
results of operations for the three months ended June 30, 2008 are not
necessarily indicative of results to be expected for the entire
year.
 
 Our
consolidated financial statements contemplate the realization of assets and the
satisfaction of liabilities in the normal course of business. We incurred a net
loss of ($792) and ($638) for the
periods ended June 30, 2008 and 2007, respectively. We used cash flows from
operations of ($927) and ($2,325) for the periods ended June 30, 2008 and 2007,
respectively.  In fiscal 2008 we financed our operations through net
cash provided by operations and from the release of $14,705 from litigation
suspense related to the settlement of the AMS litigation (See 7. Legal
Proceedings).  In fiscal 2007 we financed our operations through the
use of outstanding cash balances.  We believe that these proceeds,
combined with continued cost containment, will be adequate to fund operations
through the next twelve months.  However, projected sales may not
materialize and unforeseen costs may be incurred.If the projected
sales do not materialize, we will need to reduce expenses further and raise
additional capital through the issuance of debt or equity securities. If
additional funds are raised through the issuance of preferred stock or debt,
these securities could have rights, privileges or preferences senior to those of
common stock, and debt covenants could impose restrictions on our operations.
The sale of equity or debt could result in additional dilution to current
stockholders, and such financing may not be available to us on acceptable terms,
if at all.
 
 Concentration
of Credit Risk
 
 Financial
instruments that potentially subject the Company to significant concentrations
of credit risk consist primarily of cash investments and accounts receivable.
Substantially all of the Company’s liquid investments are invested in money
market funds. The Company’s accounts receivable are derived primarily from sales
to customers located in the U.S., Europe and Asia. The Company performs ongoing
credit evaluations of its customers and generally requires no collateral. The
Company maintains reserves for potential credit losses. Write-offs during the
periods presented have been insignificant. As of June 30, 2008 two customers
accounted for approximately 60% of the accounts receivable
balance.  As of June 30, 2007 two customers accounted for
approximately 71% of the accounts receivable balance.
 
 During
the quarter ended June 30, 2008, SVTC Tech LLC and Diodes Fab Tech Inc,
accounted for 37% and 25% respectively, of our total revenue.  During
the quarter ended June 30, 2007 ST Microelectronics accounted for 68% of total
revenues.
 
 Stock
Based Compensation
 
 The
Company has adopted several stock plans that provide for the issuance of equity
instruments to the Company’s employees and non-employee directors. The Company’s
plans include incentive and non-statutory stock options and restricted stock
awards. Stock options and restricted stock awards generally vest ratably over a
four-year period on the anniversary date of the grant, and expire ten years
after the grant date.  On occasion restricted stock awards may vest on
the achievement of specific performance targets.  The Company also has
employee stock purchase plans that allow qualified employees to purchase Company
shares at 85% of the lower of the stock’s market value on specified
dates.
 
 Prior to
April 1, 2006 the Company accounted for these stock-based employee compensation
plans under the measurement and recognition provisions of Accounting Principles
Board Opinion No. 25, “Accounting for Stock Issued to Employees” or APB 25, and
related interpretations, as permitted by Statement of Financial Accounting
Standards No. 123,, “Accounting for Stock Based
Compensation,” (“SFAS 123”).  With the exception of grants of
restricted stock awards, the Company generally recorded no stock-based
compensation expense during periods prior to April 1, 2006 as all stock-based
grants had exercise prices equal to the fair market value of the Company’s
common stock on the date of grant.  The Company also recorded no
compensation expense in connection with the Company’s employee stock purchase
plans as they qualified as non-compensatory plans following the guidance
provided by APB 25.
 
 Effective
April 1, 2006, the Company adopted the fair value recognition provisions of SFAS
No. 123 (revised 2004) “Accounting for Stock Based Compensation” (“SFAS 123R”)
using the modified prospective transition method. Under that transition method,
the Company recognized compensation expense of $1,022 for the fiscal year 2008
and $1,664 for the fiscal year 2007, which included: (a) compensation expense
for all share-based payments granted prior to but not yet vested as of April 1,
2006, based on the grant date fair value estimated in accordance with the
original provisions of SFAS 123, and (b) compensation expense for all
share-based payments granted or modified on or after April 1, 2006, based on the
grant date fair value estimated in accordance with the provisions of SFAS 123R.
Compensation expense is recognized only for those awards that are expected to
vest, whereas prior to the adoption of SFAS 123R, the Company recognized
forfeitures as they occurred. In addition, the Company elected the straight-line
attribution method as our accounting policy for recognizing stock-based
compensation expense for all awards that are granted on or after April 1,
2006.  Results in prior periods have not been restated.
 
 Total
compensation expense related to non-vested awards not yet recognized for the
periods ended June 30, 2008 and 2007 was $344 and $388,
respectively.  The weighted average period for which it is expected to
be recognized is 2 years.
 
 The
Company used the following valuation assumptions to estimate the fair value of
options granted for the periods ended June 30, 2008 and 2007
respectively:
 
 STOCK
      OPTIONS:
              
              2008
              
              
              2007Expected
      life (years)
              
              
              4.0
              
              
              
              4.0Volatility
              
              
              67.2
              %
              
              
              82.4
              %Risk-free
      interest rate
              
              
              3.59
              %
              
              
              5.25
              %Dividend
      yield
              
              
              0
              %
              
              
              0
              %
 
 ESPP
awards were valued using the Black-Scholes model with expected volatility
calculated using a six-month historical volatility.
 
 ESPP:
              
              2008
              
              
              2007Expected
      life (years)
              
              
              0.5
              
              
              
              0.5Volatility
              
              
              74.4
              %
              
              
              44.5
              %Risk-free
      interest rate
              
              
              1.87
              %
              
              
              4.99
              %Dividend
      yield
              
              
              0
              %
              
              
              0
              %
  During
the three months ended June 30, 2008, there were 57,719 stock option awards
granted.
 
 - 6
-
 Stock
Options & Warrants
 
 A
summary of stock option and warrant activity during the quarter ended June 30,
2008 is as follows:
 
 WeightedWeighted
              
              AverageAverage
              
              Remaining
              AggregateExercise
              
              Contractual
              IntrinsicShares
              
              
              Price
              
              Term
      (in Years)
              ValueBeginning
      outstanding
              
              
              2,207,307
              
              
              $
              10.72GrantedPrice
      = market value
              
              
              57,719
              
              
              $
              3.99Total
              
              
              57,719
              
              
              $
              3.99Exercised
              
              
              —
              
              
              $
              0.00CancelledForfeited
              
              
              (937
              )
              
              $
              4.60Expired
              
              
              (4,919
              )
              
              $
              12.97Total
              
              
              (5,856
              )
              
              $
              11.63Ending
      outstanding
              
              
              2,259,170
              
              
              $
              10.55
              
              4.30
              $10Ending
      vested and expected to vest
              
              
              2,227,883
              
              
              $
              10.64
              
              4.23
              $9Ending
      exercisable
              
              
              1,786,538
              
              
              $
              12.16
              
              3.04
              $0
 
 The
aggregate intrinsic value of options and warrants outstanding at June 30, 2008
is calculated as the difference between the exercise price of the underlying
options and the market price of our common stock as of June 30,
2008.
 
 The
following table summarizes information with respect to stock options and
warrants outstanding as of June 30, 2008:
 
 WeightedNumber
              
              
              Average
              
              
              
              
              
              Number
              
              
              WeightedOutstanding
              
              
              Remaining
              
              
              
              
              
              Exercisable
              
              
              AverageRange
      of
                Exercise Prices
              
              
              As
      of
                June
      30,
                2008
              
              
              Contractual
                Term
                (in
      years)
              
              
              Weighted
      Average
                Exercise
      Price
              
              
              As
      of
                June
      30,
                2008
              
              
              Exercise
      Price
                As
      of June 30,
                2008$
              3.94
              
              
              $
              3.94
              
              
              
              47,500
              
              
              
              9.89
              
              
              $
              3.94
              
              
              
              0
              
              
              $
              0.004.20
              
              
              
              4.20
              
              
              
              226,918
              
              
              
              9.47
              
              
              
              4.20
              
              
              
              83
              
              
              
              4.204.60
              
              
              
              4.60
              
              
              
              270,899
              
              
              
              8.34
              
              
              
              4.60
              
              
              
              98,047
              
              
              
              4.604.63
              
              
              
              7.08
              
              
              
              239,066
              
              
              
              5.15
              
              
              
              6.09
              
              
              
              214,871
              
              
              
              6.107.20
              
              
              
              8.28
              
              
              
              59,162
              
              
              
              6.96
              
              
              
              8.19
              
              
              
              59,162
              
              
              
              8.1912.00
              
              
              
              12.00
              
              
              
              1,284,990
              
              
              
              2.18
              
              
              
              12.00
              
              
              
              1,284,990
              
              
              
              12.0012.36
              
              
              
              92.26
              
              
              
              123,556
              
              
              
              2.99
              
              
              
              27.58
              
              
              
              122,306
              
              
              
              27.7092.52
              
              
              
              92.52
              
              
              
              4,165
              
              
              
              1.63
              
              
              
              92.52
              
              
              
              4,165
              
              
              
              92.5299.00
              
              
              
              99.00
              
              
              
              2,498
              
              
              
              1.74
              
              
              
              99.00
              
              
              
              2,498
              
              
              
              99.00105.00
              
              
              
              105.00
              
              
              
              416
              
              
              
              4.23
              
              
              
              105.00
              
              
              
              416
              
              
              
              105.00$
              3.94
              
              
              $
              105.00
              
              
              
              2,259,170
              
              
              
              4.30
              
              
              $
              10.55
              
              
              
              1,786,538
              
              
              $
              12.16
 
 
 Restricted
Stock Units
 
 The
following table summarizes the Company’s restricted stock award activity for the
three months ended June 30, 2008
 
 Number
                of
                Shares
              
              
              Weighted
      Average
                Grant
      Date
                Fair ValueBalance,
      March 31, 2008
              
              
              349,718
              
              
              $
              4.97Released
              
              
              (20,600
              )
              
              $
              4.40Forfeited
              
              
              (937
              )
              
              $
              2.46Balance,
      June 30,2008
              
              
              328,181
              
              
              $
              4.14
 
 Unvested
restricted stock at June 30, 2008
 
 As of
June 30, 2008 there was $744 of total unrecognized compensation cost related to
restricted stock which is expected to be recognized over a period of 1.58
years.
 
 2.      Inventories:
 
 Inventories
are stated at the lower of cost or market, reduced by provisions for excess and
obsolescence. Cost is computed using standard cost, which approximates actual
cost on a first-in, first-out basis and includes material, labor and
manufacturing overhead costs. We estimate the effects of excess and obsolescence
on the carrying values of our inventories based upon estimates of future demand
and market conditions. We establish provisions for related inventories in excess
of production demand. Should actual production demand differ from our estimates,
additional inventory write-downs may be required.  Any excess and
obsolete provision is released only if and when the related inventory is sold or
scrapped.  During the three months ended June 30, 2008 and June 30,
2007, the Company sold or scrapped previously reserved inventory of $4and$137respectively.The inventory provisionbalanceat June 30,
2008and June 30,2007was$3,691and$3,771,
respectively
 
 
 Inventories
for the periods presented consisted of:
 
 June
      30,
                2008
              
              
              March
      31,
                2008Raw
      materials
              
              $
              4,319
              
              
              $
              4,674Work
      in
      progress
              
              
              4,597
              
              
              
              4,663Finished
      goods and
      spares
              
              
              2,093
              
              
              
              1,719$
              11,009
              
              
              $
              11,056
 
 We
periodically analyze any systems that are in finished goods inventory to
determine if they are suitable for current customer requirements.  At
the present time, our policy is that, if after approximately 18 months, we
determine that a sale will not take place within the next 12 months and the
system would be useable for customer demonstrations or training, it is
transferred to fixed assets.  Otherwise, it is expensed.
 
 3.      Product
Warranty:
 
 The
Company provides warranty on all system sales based on the estimated cost of
product warranties at the time revenue is recognized.  The warranty
obligation is affected by product failure rates, material usage rates, and the
efficiency by which the product failure is corrected.  Warranty
activity for the three-months ended June 30, 2008 and 2007 is as
follows:
 
 Warranty
      Activity for the
                Three
      Months Ended
                June 30,2008
              
              
              2007Balance
      at the beginning of the period
              
              $
              1,770
              
              
              $
              1,101Additional
      warranty accruals for warranties issued during the period
              
              
              162
              
              
              
              247Less
      settlements made during the period
              
              
              (617
              )
              
              
              (157
              )Balance
      at the end of the period
              
              $
              1,315
              
              
              $
              1,191
 
 Certain
of the Company's sales contracts include provisions under which customers would
be indemnified by the Company in the event of, among other things, a third-party
claim against the customer for intellectual property rights infringement related
to the Company's products. There are no limitations on the maximum potential
future payments under these guarantees. The Company has accrued no amounts in
relation to these provisions as no such claims have been made and the Company
believes it has valid, enforceable rights to the intellectual property embedded
in its products.
 
 - 7
-
 4.      Net
Loss Per Common Share:
 
 Basic EPS
is computed by dividing income (loss) available to common stockholders
(numerator) by the weighted average number of common shares outstanding
(denominator) for the period. For periods of positive income, diluted EPS gives
effect to all dilutive potential common shares outstanding during the period.
The computation of diluted EPS uses the average market prices during the period.
All amounts in the following table are in thousands except per share
data.  In periods of negative income, all dilutive securities are
anti-dilutive.
 
 Basic net
loss per common share is computed using the weighted-average number of shares of
common stock outstanding.
 
 The
following table represents the calculation of basic and diluted net loss per
common share (in thousands, except per share data):
 
 Three Months EndedJune 30,2008
              
              
              2007Net
      loss applicable to common
      stockholders
              
              $
              (792
              )
              
              $
              (638
              )Basic
      and diluted:Weighted-average
      common shares outstanding
              
              
              7,177
              
              
              
              7,110Less
      weighted-average common shares subject to repurchase
              
              
              —
              
              
              
              —Weighted-average
      common shares used in computing basic net loss per common
      share
              
              
              7,177
              
              
              
              7,110Plus
      diluted - common stock
      equivalents
              
              
              —
              
              
              
              —Weighted-average
      common shares used in diluted net loss per common share
              
              
              7,177
              
              
              
              7,110Basic
      net loss per common
      share
              
              $
              (.11
              )
              
              $
              (.09
              )Diluted
      net loss per common
      share
              
              $
              (.11
              )
              
              $
              (.09
              )
 
 Outstanding
options, warrants and restricted stock equivalent of 2,587,351 and 2,517,179
shares of common stock at a weighted-average exercise price of $9.74
and $10.44 per share on June 30, 2008 and 2007 respectively, were not
included in the computation of diluted net loss per common share for the periods
presented as a result of their anti-dilutive effect.  Such securities
could potentially dilute earnings per share in future periods.
 
 5.      Stock-Based
Transactions:
 
 Issuance
of Warrants to Consultants
 
 The
Company issued no warrants to any party in lieu of cash payments for the three
months ended June 30, 2008.  During the three months ended June 30,
2007 the Company issued 2,500 warrants valued at $9 using the Black-Scholes
model with an exercise price at the market value on the day of the grant and an
average interest rate of 4.51% and a 5 year life.
 
 6.      Lines
of Credit:
 
 The
Company has no lines of credit.
 
 7.      Legal
Proceedings
 
 Sputtered Films, Inc. v.
Advanced Modular Sputtering, et al., filed in Santa Barbara County Superior
Court.
 
 On
December 22, 2003, Sputtered Films, Inc. ("SFI"), a wholly owned subsidiary of
the Company, filed an action against two former employees, Sergey Mishin and
Rose Stuart-Curran, and a company they formed after leaving their employment
with SFI named Advanced Modular Sputtering, Inc. ("AMS").  Sergey
Mishin and Rose Stuart-Curran had each signed confidentiality and non-disclosure
agreements regarding information obtained while employed by SFI.  On
November 18, 2005, SFI added Agilent Technologies, Inc. ("Agilent") as a
defendant based on evidence that Agilent and AMS co-developed the machines which
SFI contended were built using SFI proprietary information. In early December
2005. Agilent transferred its Semiconductor Products Group to a number of Avago
entities, which were also added as defendants in this action.  On
April 25, 2006, the Avago Entities filed a Cross-Complaint against SFI and
Tegal.
 
 On
November 13, 2006, following commencement of the trial, all the parties in the
litigation agreed on terms of a settlement, which was filed with the
court.  Among other things, the settlement called for the transfer of
assets related to PVD technology from AMS to SFI, the dissolution of AMS as of
March 1, 2007 and the assumption by Tegal of certain warranty obligations of
AMS, neither of which was material.  The Avago Cross-Complaint was
also dismissed as part of the settlement. A final confidential settlement and
release of claims was executed among the parties on December 21,
2006.
  The two
law firms representing SFI in this matter claimed they were entitled, as a
result of the settlement, to receive contingent fees from Tegal and
SFI.  Keker & Van Nest LLP (“KVN”) claimed fees in the amount of
$6,717; Gonzalez & Leigh LLP (“G&L”) claimed fees in the amount of
$2,249.  We initiated proceedings with the Bar Association of San
Francisco (“BASF”), pursuant to California statutes, to dispute the claims of
both firms.  KVN filed suit against us and SFI in San Francisco
Superior Court and the action was stayed pending completion of the BASF
proceedings.  G&L did not file suit.  We identified
legal and factual defenses to substantial elements of the claims and vigorously
contested the matter.
  As a
result of the fee dispute described above, as of March 31, 2007, we had placed
$19,500, representing the gross cash proceeds from the recent settlement of this
litigation into suspense.   Since the amount disputed could not
be determined with reasonable certainty until the dispute was resolved, we
elected to suspend the entire amount, in accordance with Statement of Financial
Accounting Standards No.5, “Accounting for
Contingencies.”
  Prior to
the September 11, 2007 arbitration hearing, G&L settled its claim against
the Company for $995, and the resulting payment by the Company to G&L of
$995 was released from the litigation in suspense proceeds.  On
January 16, 2008, Tegal received a Notice of Acceptance of Written Offer to
Compromise from KVN.  In connection with KVN’s acceptance of the
Company’s Written Offer to Compromise and the execution of a mutual general
release, dated as of January 18, 2008, the Company has paid KVN $3,800. As a
result, the Company has eliminated the litigation suspense along with other
liabilities related to the AMS Settlement, and the net proceeds has been
recorded as other income in the fiscal fourth quarter ended March 31,
2008.
  - 8
-
 
 8.        Geographical
Information
 
 Tegal
operates in one segment for the manufacture, marketing and servicing of
integrated circuit fabrication equipment.  In accordance with SFAS No.
131 (“SFAS 131”) “Disclosures
About Segments of an Enterprise and Related Information,” Tegal’s chief
operating decision-maker has been identified as the President and Chief
Executive Officer, who reviews operating results to make decisions about
allocating resources and assessing performance for the entire
company.
 
 For
geographical reporting, revenues are attributed to the geographic location in
which the customers’ facilities are located.  Long-lived assets
consist of property, plant and equipment, and are attributed to the geographic
location in which they are located.  Net sales and long-lived assets
by geographic region were as follows:
 
 
 Revenue
      for the
                Three
      Months Ended
                June 30,2008
              
              
              2007Sales
      to customers located in:United
      States
              
              $
              3,708
              
              
              $
              729Asia
              
              
              452
              
              
              
              358Germany
              
              
              115
              
              
              
              574Europe,
      excluding
      Germany
              
              
              454
              
              
              
              2,937Total
      sales
              
              $
              4,729
              
              
              $
              4,598
 
 
 
 Long-lived
                Assets
      as of
                June 30,2008
              
              
              2007Long-lived
      assets at period-end:United
      States
              
              $
              1,218
              
              
              $
              1,301Europe
              
              
              15
              
              
              
              11Total
      long-lived assets
              
              $
              1,233
              
              
              $
              1,312
 
 
 9.      Recent
Accounting Pronouncements
 
 In
September 2006, FASB issued Statement of Financial Standards No. 157 (“SFAS
157”), “Fair Value Measurements”.
SFAS 157 defines fair value, establishes a framework for measuring fair
value in accordance with generally accepted accounting principles, and
expands disclosures about fair value measurements. SFAS 157 does not
require any new fair value measurements; rather, it applies under other
accounting pronouncements that require or permit fair value
measurements. The provisions of SFAS 157 are to be applied prospectively as
of the beginning of the fiscal year in which it is initially applied, with
any transition adjustment recognized as a cumulative-effect adjustment to
the opening balance of retained earnings. The provisions of SFAS 157 are
effective for fiscal years beginning after November 15,
2007.  The Company is complying with SFAS 157 as of April 1, 2008 as
follows.   The Company does not hold or issue derivatives,
commodity instruments or other financial instruments for trading
purposes.  The only assets and liabilities valued using a fair value
methodology are related to stock based compensation.  The Company has
been using this valuation method since April 1, 2006 when it adopted the fair
value recognition provisions of Statement of Financial Accounting Standards No.
123 (revised 2004), “Share
Based Payment” (SFAS 123R).
 
 In
February 2007, FASB issued SFAS No. 159, “The Fair Value Option for Financial
Assets and Liabilities” (“SFAS 159”). SFAS 159 provides entities with the
option to report selected financial assets and liabilities at fair value.
Business entities adopting SFAS 159 will report unrealized gains and losses in
earnings at each subsequent reporting date on items for which fair value option
has been elected. SFAS 159 establishes presentation and disclosure requirements
designed to facilitate comparisons between entities that choose different
measurement attributes for similar types of assets and liabilities. SFAS 159
requires additional information that will help investors and other financial
statement users to understand the effect of an entity’s choice to use fair value
on its earnings.  SFAS 159 is effective for fiscal years beginning
after November 15, 2007, with earlier adoption permitted. The Company is
complying with SFAS 159 as of April 1, 2008 as follows.   The
Company does not hold or issue derivatives, commodity instruments or other
financial instruments for trading purposes.  The only assets and
liabilities valued using a fair value methodology are related to stock based
compensation.  The Company has been using this valuation method since
April 1, 2006 when it adopted the fair value recognition provisions of Statement
of Financial Accounting Standards No. 123 (revised 2004), “Share Based Payment” (SFAS
123R).
 
 In
December 2007, FASB issued SFAS No. 141 (revised 2007), “Business Combinations”,
(“SFAS 141R”) which replaces SFAS No 141.  SFAS 141R retains the
purchase method of accounting for acquisitions, but requires a number of
changes, including changes in the way assets and liabilities are recognized in
the purchase accounting. It also changes the recognition of assets acquired and
liabilities assumed arising from contingencies, requires the capitalization of
in-process research and development at fair value, and requires the expensing of
acquisition-related costs as incurred. SFAS No. 141R is effective for the
Company beginning April 1, 2009 and will apply prospectively to business
combinations completed on or after that date.
  In
December 2007, FASB issued SFAS No. 160, “Noncontrolling Interests in
Consolidated Financial Statement, - an amendment of ARB No. 51”, (“SFAS
160”) which changes the accounting and reporting for minority
interests.  Minority interests will be recharacterized as
noncontrolling interests and will be reported as a component of equity separate
from the parent’s equity, and purchases or sales of equity interests that do not
result in a change in control will be accounted for as equity transactions. In
addition, net income attributable to the noncontrolling interest will be
included in consolidated net income on the face of the income statement and,
upon a loss of control, the interest sold, as well as any interest retained,
will be recorded at fair value with any gain or loss recognized in earnings.
SFAS No. 160 is effective for the Company beginning April 1, 2009 and will apply
prospectively, except for the presentation and disclosure requirements, which
will apply retrospectively.  SFAS 160 has no material effect on the
Company’s consolidated financial statements.
 
 In March
2008, FASB issued SFAS No. 161, “Disclosures about Derivative
Instruments and Hedging Activities—an amendment of FASB Statement No.
133” (“SFAS 161”), which requires enhanced disclosures about an entity’s
derivative and hedging activities and thereby improves the transparency of
financial reporting. The statement requires disclosure about (a) why an entity
uses derivative instruments, (b) how derivative instruments and related hedged
items are accounted for under SFAS No. 133, "Accounting for Derivative
Instruments and Hedging Activities" and its related interpretations, and (c) how
derivative instruments and related hedged items affect an entity's financial
position, financial performance, and cash flows.  SFAS 161 is
effective for fiscal years beginning after November 15, 2008.  SFAS
161 has no material effect on the Company’s consolidated financial
statements.
 
 In May
2008, FASB issued SFAS No. 162 "The Hierarchy of Generally Accepted
Accounting Principles" ("SFAS 162"). SFAS 162 identifies the sources of
generally accepted accounting principles in the United States. SFAS 162 is
effective sixty days following the SEC's approval of PCAOB amendments to AU
Section 411, "The Meaning of 'Present fairly in conformity with generally
accepted accounting principles'". The Company is currently evaluating the
potential impact, if any, of the adoption of SFAS 162 on its consolidated
financial statements.
 
 On May
23, 2008, FASB issued SFAS No. 163, “Accounting for Financial Guarantee
Insurance Contracts” (“SFAS 163”). The new standard clarifies how SFAS
60, “Accounting and Reporting
by Insurance Enterprises”, applies to financial guarantee insurance
contracts issued by insurance enterprises, including the recognition and
measurement of premium revenue and claim liabilities. It also requires expanded
disclosures about financial guarantee insurance contracts.  SFAS 163
has no material effect on the Company’s consolidated financial
statements.
 
 In June
2007, FASB’s Emerging Issues Task Force (“EITF”) reached a consensus on EITF
Issue No. 07-3, “Accounting
for Nonrefundable Advance Payments for Goods or Services to Be Used in Future
Research and Development Activities” (“EITF Issue No. 07-3”) that would
require nonrefundable advance payments made by the Company for future research
and development activities to be capitalized and recognized as an expense as the
goods or services are received by the Company. The Company does not expect EITF
Issue No. 07-3 to have a material impact on the Company’s consolidated financial
statements.
 
 In
December 2007, FASB ratified the EITF consensus on EITF Issue No. 07-1, “Accounting for Collaborative
Arrangements” that discusses how parties to a collaborative arrangement
(which does not establish a legal entity within such arrangement) should account
for various activities. The consensus indicates that costs incurred and revenues
generated from transactions with third parties (i.e., parties outside of the
collaborative arrangement) should be reported by the collaborators on the
respective line items in their income statements pursuant to EITF Issue No.
99-19, “Reporting Revenue
Gross as a Principal Versus Net as an Agent.”  Additionally,
the consensus provides that income statement characterization of payments
between the participants in a collaborative arrangement should be based upon
existing authoritative pronouncements, analogy to such pronouncements if not
within their scope, or a reasonable, rational, and consistently applied
accounting policy election. EITF Issue No. 07-1 is effective for fiscal years
beginning after December 15, 2008 and is to be applied retrospectively to all
periods presented for collaborative arrangements existing as of the date of
adoption. The Company is currently evaluating the impacts and disclosures of
this standard, but would not expect EITF Issue No. 07-1 to have a material
impact on the Company’s consolidated financial statements.
 
 - 9
-
 
 Item
2.   Management’s Discussion and Analysis
of Financial Condition and Results of Operations– (Amounts in
000’s)
 
 Special
Note Regarding Forward Looking Statements
 
 Information
contained or incorporated by reference in this report contains forward-looking
statements.  These forward-looking statements are based on current
expectations and beliefs and involve numerous risks and uncertainties that could
cause actual results to differ materially from expectations.  These
forward-looking statements should not be relied upon as predictions of future
events as we cannot assure you that the events or circumstances reflected in
these statements will be achieved or will occur.  You can identify
forward-looking statements by the use of forward-looking terminology such as
“may,” “will,” “expect,” “anticipate,” “estimate” or “continue” or the negative
thereof or other variations thereon or comparable terminology which constitutes
projected financial information.  These forward-looking statements are
subject to risks, uncertainties and assumptions about Tegal
Corporation  including, but not limited to, industry conditions,
economic conditions, acceptance of new technologies and market acceptance of
Tegal Corporation’s  products and service.  For a discussion
of the factors that could cause actual results to differ materially from the
forward-looking statements, see the “Part Item 1A—Risk Factors” and the
“Liquidity and Capital Resources” section set forth in this
section  and such other risks and uncertainties as set forth below in
this report or detailed in our other SEC reports and filings. We assume no
obligation to update forward-looking statements.
 
 Tegal
Corporation, a Delaware corporation (“Tegal” or the “Company”), designs,
manufactures, markets and services plasma etch and deposition systems that
enable the production of integrated circuits (“ICs”), memory and related
microelectronics devices used in portable computers, cellphones, PDAs and RFID
applications; megapixel imaging chips used in digital and cellphone cameras;
power amplifiers for portable handsets and wireless networking gear; and MEMS
devices like accelerometers for automotive airbags, microfluidic control devices
for ink jet printers; and laboratory-on-a-chip medical test
kits.  Etching and deposition constitute two of the principal IC and
related device production process steps and each must be performed numerous
times in the production of such devices.
 
 Semiconductor
Industry Background
 
 Over the
past twenty years, the semiconductor industry has experienced significant
growth. This growth has resulted from the increasing demand for ICs from
traditional IC markets, such as personal computers, telecommunications, consumer
electronics, automotive electronics and office equipment, as well as developing
markets, such as wireless communications, multimedia and portable and network
computing. As a result of this increased demand, semiconductor device
manufacturers have periodically expended significant amounts of capital to build
new semiconductor fabrication facilities (“fabs”) and to expand existing
fabs.  More recently, growth has slowed, and the industry is maturing
as the cost of building new wafer fabs has increased
dramatically.  While unit demand for semiconductor devices continue to
rise, the average selling prices of chips continue to decline.  There
is growing pressure on semiconductor device manufacturers to reduce
manufacturing costs while increasing the value of their products.  The
semiconductor industry has also been historically cyclical, with periods of
rapid expansion followed by periods of over-capacity.  Currently, the
industry is experiencing a down-turn, hightened by tighter credit markets and
the negative economic environment.  These circumstances have caused
customers to delay or reconsider expenditures on capital equipment. While we
have seen our customers’ capital expenditures slow recently, we expect our
customers’ capital spending to increase over the long term as demand from
various industries continues to steadily rise.
 
 Growth in
the semiconductor industry has been driven, in large part, by advances in
semiconductor performance at a decreasing cost per function. Advanced
semiconductor processing technologies increasingly allow semiconductor
manufacturers to produce ICs with smaller features, thereby increasing
processing speed and expanding device functionality and memory capacity. As ICs
have become more complex, however, both the number and price of state of the art
process tools required to manufacture ICs have increased significantly. As a
result, the cost of semiconductor manufacturing equipment has become an
increasingly large part of the total cost of producing advanced
ICs.
 
 To create
an IC, semiconductor wafers are subjected to a large number of complex process
steps. The three primary steps in manufacturing ICs are (1) deposition, in which
a layer of insulating or conducting material is deposited on the wafer surface,
(2) photolithography, in which the circuit pattern is projected onto a light
sensitive material (the photoresist), and (3) etch, in which the unmasked parts
of the deposited material on the wafer are selectively removed to form the IC
circuit pattern.
 
 Each step of the manufacturing process for ICs requires specialized
manufacturing equipment. Today, plasma-based systems are used for the great
majority of both deposition and etching processes. During physical vapor
deposition the semiconductor wafer is exposed to a plasma environment that forms
continuous thin films of electrically insulating or electrically conductive
layers on the semiconductor wafer. During a plasma etch process (also known as
“dry etch”), a semiconductor wafer is exposed to a plasma composed of a reactive
gas, such as chlorine, which etches away selected portions of the layer
underlying the patterned photoresist layer.
 
 Business
Strategy
 
 Our
business objective is to utilize the technologies that we have developed
internally or acquired externally in order to increase our market share in
process equipment for both semiconductor manufacturing and nanotechnology device
fabrication (i.e.. devices smaller than about 100
nanometers).   In the recent past, we have focused on competing
with more established competitors by being “designed-in” to the advanced device
fabrication plans of our customers.  We have done so primarily by
engaging in research and development activities on behalf of our customers that
our more established competitors were unwilling or unable to
perform.  Many of these advanced devices promise substantial returns
as consumer demand for certain functions grows and new markets are
created.  However, the timing of the emergence of such demand is
highly uncertain.  In addition, the successful integration by our
customers of all the various technical processes required to manufacture a
device at an acceptable cost is also highly uncertain.  We cannot
accurately predict the timing of the stable emergence of these
markets.  Due to the cyclical nature of our industry, we expect that
net orders will continue to fluctuate.  In the meantime, our costs for
maintaining our research and development efforts and our service and
manufacturing infrastructure have remained constant or in some cases
increased.
 
 At the
present time, we are continuing our transition of the Company’s dependence on
these highly unpredictable markets to more established equipment markets, where
our success is dependent more on our ability to apply successfully our
engineering capabilities to solving existing manufacturing
problems.  We aim to carefully manage this transition by limiting our
research and development efforts to the most promising near-term sales
opportunities, while at the same time redirecting all our available resources
toward new products aimed at established equipment markets.  Because
of our relatively small size, our ability to meet the needs of individual
customers is far more important to our success than either macroeconomic factors
or industry-wide factors such as cyclicality, although both of these factors
affect our performance as well.  As a result, our methods of
evaluating our progress will continue to be highly
customer-focused.
 
 In order
to achieve our business strategy, we are focused on the following key
elements:
 
 Maintaining our Technology
Leadership Position in New Materials Etch – We are a leading provider of
etch process solutions for a set of new materials central to the production of
an array of advanced semiconductor and nanotechnology devices in emerging
markets.  Incorporation of these new materials is essential to
achieving the higher device densities, lower power consumption and novel
functions exhibited by the newest generation of cell phones, computer memories,
fiber optic switches and remote sensors.  Currently, we are a leading
supplier of etch solutions to makers of various advanced “non-volatile”
memories, as well as to device makers incorporating compound metals and certain
high-K dielectric materials into their devices.  Our new materials
expertise also includes the etching of so-called “compound-semi” materials, such
as gallium arsenide, gallium nitride and indium phosphide, widely used in
telecom device production, as well as expanding use in growth markets such as
mobile terminals, digital home appliances as well as enterprise applications,
such as wireless local area networks.   The advantages of
compound semiconductor devices over traditional silicon devices include higher
operating speeds, lower power consumption, reduced noise and distortion, higher
operable temperature, light emitting and detecting properties, higher light
emission efficiency and longer product life.In
addition, we are known for our capability to etch certain noble metals, such as
gold and platinum, as well as certain proprietary compound
metals.  This capability is increasingly important in advanced memory
development and in the production of Micro-Electrical Mechanical Systems
(“MEMS”), a type of commercially produced nanotechnology device, especially
useful to the automotive industry.  We intend to maintain our
leadership position in new materials etch through our own internal development
efforts and through various joint development programs and production efforts
with leading device manufacturers.
 
 Strengthening our Position in
Deposition Process Equipment – Since 2002, we have completed two
acquisitions of deposition products incorporating the same unique “sputter-up”
technology.  In December 2006, as a result of the settlement of our
litigation with Advanced Modular Systems (“AMS”) and others, we also acquired
the assets and know-how of a similar deposition system.  These
deposition tools enable the production of highly-oriented, thin piezoelectric
films composed of aluminum nitride.  Such films are incorporated into
high frequency filters called Bulk Acoustic Wave (“BAW”) and Film Bulk Acoustic
Resonators (“FBARs”) used in cellular telephone and wireless
communications.   In addition our PVD products are well-suited
for applications within so-called “back-end” semiconductor manufacturing
processes, including backside metallization of ultra-thin wafers and underbump
metal processes.  These processes are important to power devices, as
well as certain advanced, wafer-level packaging schemes, which are increasingly
being used for high-pin-count logic and memory devices.
 
 Introducing a New Product into
Established Equipment Market - The continued development of our NLD
technology represents our belief that we have a compelling solution to a
critical process need in present-day and future semiconductor device
fabrication.  As device geometries continue to shrink, conventional
chemical vapor deposition (“CVD”) process equipment is increasingly incapable of
depositing thin conformal films in high-aspect ratio trenches and
vias.  In addition, there appear to be significant applications of our
NLD technology in barrier films and high-K materials
deposition.  Atomic Level Deposition (“ALD”) is one technology for
satisfying this deposition requirement.  However, ALD has several
shortcomings, including low throughput and limitations on film type and quality,
which we believe our NLD technology overcomes.
 
 Maintaining our Service Leadership
Position --   Tegal has been consistently recognized by
our customers for providing a high level of customer support, a fact that has
been noted by our top rankings for several consecutive years in the annual
survey conducted by VLSI Research, Inc.  We expect to maintain and
build on this reputation as we seek new customers in both emerging and
established markets.
 
 - 10
-
 Critical
Accounting Policies and Estimates
 
 Our
discussion and analysis of our financial condition and results of operations are
based upon our consolidated financial statements, which have been prepared in
accordance with accounting principles generally accepted in the United States of
America. The preparation of these financial statements requires us to make
estimates and judgments that affect the reported amounts of assets, liabilities,
revenues and expenses, and related disclosure of contingent assets and
liabilities. On an on-going basis, we evaluate our estimates, including those
related to revenue recognition, bad debts, sales returns allowance, inventory,
intangible and long lived assets, warranty obligations, restructure expenses,
deferred taxes and freight charged to customers. We base our estimates on
historical experience and on various other assumptions that we believe to be
reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions.
 
 We
believe the following critical accounting policies are the most significant to
the presentation of our consolidated financial statements:
 
 Revenue
Recognition
 
 Each sale
of our equipment is evaluated on an individual basis in regard to revenue
recognition.  We have integrated in our evaluation the related
interpretative guidance included in Topic 13 of the codification of staff
accounting bulletins, and recognize the role of the Emerging Issues Task Force
(“EITF”) consensus on Issue 00-21.  We first refer to EITF 00-21 in
order to determine if there is more than one unit of accounting and then we
refer to SAB104 for revenue recognition topics for the unit of accounting. We
recognize revenue when persuasive evidence of an arrangement exists, the
seller’s price is fixed or determinable and collectability is reasonably
assured.
 
 For
products produced according to our published specifications, where no
installation is required or installation is deemed perfunctory and no
substantive customer acceptance provisions exist, revenue is recognized when
title passes to the customer, generally upon shipment. Installation is not
deemed to be essential to the functionality of the equipment since installation
does not involve significant changes to the features or capabilities of the
equipment or building complex interfaces and connections.  In
addition, the equipment could be installed by the customer or other vendors and
generally the cost of installation approximates only 1% of the sales value of
the related equipment.
 
 For
products produced according to a particular customer’s specifications, revenue
is recognized when the product has been tested and it has been demonstrated that
it meets the customer’s specifications and title passes to the
customer.  The amount of revenue recorded is reduced by the amount
(generally 10%), which is not payable by the customer until installation is
completed and final customer acceptance is achieved.
 
 For new
products, new applications of existing products, or for products with
substantive customer acceptance provisions where performance cannot be fully
assessed prior to meeting customer specifications at the customer site, 100% of
revenue is recognized upon completion of installation and receipt of final
customer acceptance.  Since title to goods generally passes to the
customer upon shipment and 90% of the contract amount becomes payable at that
time, inventory is relieved and accounts receivable is recorded for the entire
contract amount.  The revenue on these transactions is deferred and
recorded as deferred revenue.  We reserve for warranty costs at the
time the related revenue is recognized.
 
 Revenue
related to sales of spare parts is recognized upon shipment.  Revenue
related to maintenance and service contracts is recognized ratably over the
duration of the contracts.  Unearned maintenance and service revenue
is included in deferred revenue.
 
 Accounting
for Stock-Based Compensation
 
 We have
adopted several stock plans that provide for issuance of equity instruments to
our employees and non-employee directors. Our plans include incentive and
non-statutory stock options and restricted stock awards. Stock options and
restricted stock awards generally vest ratably over a four-year period on the
anniversary date of the grant, and expire ten years after the grant
date.  Certain restricted stock awards may vest on the achievement of
specific performance targets.  We also have employee stock purchase
plans that allow qualified employees to purchase Tegal shares at 85% of the fair
market value on specified dates.
 
 Prior to
April 1, 2006 we accounted for these stock-based employee compensation plans
under the measurement and recognition provisions of Accounting Principles Board
Opinion No.25, “Accounting for
Stock Issued to Employees,” or APB 25, and related interpretations, as
permitted by Statement of Financial Accounting Standards (“SFAS”) No. 123,
“Accounting for Stock Based
Compensation” (SFAS 123).  With the exception of grants of
restricted stock awards, we generally, recorded no stock-based compensation
expense during periods prior to April 1, 2006 as all stock-based grants had
exercise prices equal to the fair market value of our common stock on the date
of grant.  We also recorded no compensation expense in connection with
our employee stock purchase plan as they qualified as a non-compensatory plan
following the guidance provided by APB 25.
 
 Effective
April 1, 2006, we adopted the fair value recognition provisions of Statement of
Financial Accounting Standards No. 123 (revised 2004), “Share Based Payment” (SFAS
123R) using the modified prospective transition method. Under that transition
method, we recognized compensation expense of $1,022 for the fiscal year 2008
and $1,664 for the fiscal year 2007, which included: (a) compensation expense
for all share-based payments granted prior to but not yet vested as of April 1,
2006, based on the grant date fair value estimated in accordance with the
original provisions of SFAS 123, and (b) compensation expense for all
share-based payments granted or modified on or after April 1, 2006, based on the
grant date fair value estimated in accordance with the provisions of SFAS 123R.
Compensation expense is recognized only for those awards that are expected to
vest, whereas prior to the adoption of SFAS 123R, we recognized forfeitures as
they occurred. In addition, we elected the straight-line attribution method as
our accounting policy for recognizing stock-based compensation expense for all
awards that are granted on or after April 1, 2006.  Results in prior
periods have not been restated.
 
 Accounts
Receivable – Allowance for Sales Returns and Doubtful Accounts
 
 The
Company maintains an allowance for doubtful accounts receivable for estimated
losses resulting from the inability of the Company’s customers to make required
payments. If the financial condition of the Company’s customers were to
deteriorate, or even a single customer was otherwise unable to make payments,
additional allowances may be required.  As of June 30, 2008 two
customers accounted for approximately 60% of the accounts receivable
balance.  As of June 30, 2007 two customers accounted for
approximately 71% of the accounts receivable balance.
 
 The
Company’s return policy is for spare parts and components only.  A
right of return does not exist for systems. Customers are allowed to return
spare parts if they are defective upon receipt. The potential returns are offset
against gross revenue on a monthly basis.  Management reviews
outstanding requests for returns on a quarterly basis to determine that the
reserves are adequate.
 
 Inventories
 
 Inventories
are stated at the lower of cost or market, reduced by provisions for excess and
obsolescence. Cost is computed using standard cost, which approximates actual
cost on a first-in, first-out basis and includes material, labor and
manufacturing overhead costs. We estimate the effects of excess and obsolescence
on the carrying values of our inventories based upon estimates of future demand
and market conditions. We establish provisions for related inventories in excess
of production demand. Should actual production demand differ from our estimates,
additional inventory write-downs may be required. Any excess and obsolete
provision is released only if and when the related inventories is sold or
scrapped.   The inventory provision balance at June 30, 2008 and
March 31, 2008 was $3,691and $3,695,
respectively.  The recovery of previously reserved inventory upon sale
of such inventory for the three months ended June 30, 2008 and June 30, 2007
was $4and$137,
respectively.
 
 The
Company periodically analyzes any systems that are in finished goods inventory
to determine if they are suitable for current customer
requirements.  At the present time, the company’s policy is that, if
after approximately 18 months, it determines that a sale will not take place
within the next 12 months and the system would be useable for customer
demonstrations or training, it is transferred to fixed
assets.  Otherwise, it is expensed.
 
 The
carrying value of systems used for demonstrations or training is determined by
assessing the cost of the components that are suitable for sale.  Any
parts that may be rendered unsaleable as a result of such use are removed from
the system and are not included in finished goods inventory. The remaining
saleable parts are valued at the lower of cost or market, representing the
system’s net realizable value.   The depreciation period for
systems that are transferred to fixed assets is determined based on the age of
the system and its remaining useful life (typically five to eight
years).
 
 - 11
-
 Impairment
of Long-Lived Assets
 
 Long-lived
assets are reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amount may not be recoverable. If undiscounted
expected future cash flows are less than the carrying value of the assets, an
impairment loss is recognized based on the excess of the carrying amount over
the fair value of the assets. No impairment charge has been recorded for the
years ended 2008 and 2007.
 
 Warranty
Obligations
 
 We
provide for the estimated cost of our product warranties at the time revenue is
recognized. Our warranty obligation is affected by product failure rates,
material usage rates and the efficiency by which the product failure is
corrected.  The warranty reserve is based on historical cost data
related to warranty.  Should actual product failure rates, material
usage rates and labor efficiencies differ from our estimates, revisions to the
estimated warranty liability may be required.  Of the $617 in warranty
settlements in the three months ended June 30 2008, $200 relates to the
finalization of installation amortization on several systems sold in the fiscal
year just ended.  The balance of the settlements is warranty
amortization net actual warranty expense.   Actual warranty
expense is typically low in the period immediately following
installation.
 
 Deferred
Taxes
 
 We record
a valuation allowance to reduce our deferred tax assets to the amount that is
more likely than not to be realized. Based on the uncertainty of future taxable
income, we have fully reserved our deferred tax assets. In the event we were to
determine that we would be able to realize our deferred tax assets in the
future, an adjustment to the deferred tax asset would increase income in the
period such determination was made.
 
 Results
of Operations
 
 The
following table sets forth certain financial items as a percentage of revenue
for the three months ended June 30, 2008 and 2007:
 
 Three
      Months Ended
                June 30,2008
              
              
              2007Revenue
              
              
              100.0
              %
              
              
              100.0
              %Cost
      of
      revenue
              
              
              50.8
              %
              
              
              64.7
              %Gross
      profit
              
              
              49.2
              %
              
              
              35.3
              %Operating
      expenses:Research
      and
      development
              
              
              24.0
              %
              
              
              16.9
              %Sales
      and
      marketing
              
              
              17.8
              %
              
              
              21.9
              %General
      and
      administrative
              
              
              28.2
              %
              
              
              26.2
              %Total
      operating
      expenses
              
              
              70.0
              %
              
              
              65.0
              %Operating
      income
      (loss)
              
              
              (20.8
              )%
              
              
              (29.7
              )%Other
      income (expense),
      net
              
              
              4.0
              %
              
              
              15.8
              %Income
      (loss) before income tax expense
      (benefit)
              
              
              (16.8
              )%
              
              
              (13.9
              )%Net
      loss
              
              
              (16.8
              )%
              
              
              (13.9
              )%
 
 The
following table sets forth certain financial items for the three months ended
June 30, 2008 and 2007:
 
 Three
      MonthsEnded
                June 30,2008
              
              
              2007Revenue
              
              $
              4,729
              
              
              $
              4,598Cost
      of
      revenue
              
              
              2,402
              
              
              
              2,977Gross
      profit
              
              
              2,327
              
              
              
              1,621Operating
      expenses:Research
      and
      development
              
              
              1,136
              
              
              
              778Sales
      and
      marketing
              
              
              843
              
              
              
              1,006General
      and
      administrative
              
              
              1,330
              
              
              
              1,203Total
      operating
      expenses
              
              
              3,309
              
              
              
              2,987Operating
      loss
              
              
              (982
              )
              
              
              (1,366
              )Other
      income,
      net
              
              
              190
              
              
              
              728Loss
      before income tax expense (benefit)
              
              
              (792
              )
              
              
              (638
              )Income
      tax expense
      (benefit)
              
              
              —
              
              
              
              —Net
      loss
              
              $
              (792
              )
              
              $
              (638
              )Net
      loss per share:Basic
              
              $
              (0.11)
              
              
              $
              (0.09)Diluted
              
              $
              (0.11)
              
              
              $
              (0.09)Weighted
      average shares used in per share computation:Basic
              
              
              7,177
              
              
              
              7,110Diluted
              
              
              7,177
              
              
              
              7,110
 
 
 - 12
-
 Revenue
 
 Revenue for the three
months ended June 30, 2008 was due principally to the sale of two used systems;
one advanced etch and one Endeavor.  Revenue for the three months
ended June 30, 2007 was due principally to the sale of one new advanced
system.
 
 International
sales accounted for approximately 21.6% and 84.1% of total revenue for the three months ended
June 30, 2008 and 2007, respectively.   We believe that
international sales will continue to represent a significant portion of our
revenue.
 
 Gross
profit
 
 Gross
profit for the three months ended June 30, 2008 increased $706to
$2,327.  This was a 43.6% increase from the three months ended June
30, 2007.  The increase in gross profit was attributable to
warranty costs, net of amortization, being significantly lower due to timing of
installation amortization finalization, lower field service overhead costs and
the annual material cost update of inventory, which was partially offset by
higher manufacturing overhead variances related to the production
schedule.  Also cost containment helped maintain our usual product
structure profit margin.  While the company has improved warranty
related training of some of its regional field service engineers, it is not
certain that the lower cost trend will continue.  Our gross profit
margin for the three months ended June 20, 2008 was 49.2% compared to 35.3% for
the same period last year.
 
 Research and
Development
 
 Research and
development expenses consist primarily of salaries, prototype material and other
costs associated with our ongoing systems and process technology development,
applications and field process support efforts. The comparative increase of $358
in research and development spending for the three months ended June 30, 2008
resulted from reimbursement for prototype costs during the prior year first
quarter.
 
 Sales and
Marketing
 
 Sales and marketing
expenses consist primarily of salaries, commissions, trade show promotion and
travel and living expenses associated with those functions. The decrease of $163
in sales and marketing spending for the three months ended June 30, 2008 was
primarily due to the
decrease of outside agent commissions for systems over the same period last year
combined with decreased spending on travel expenses.
 
 General
and Administrative
 
 General
and administrative expenses consist primarily of compensation for general
management, accounting and finance, human resources, information systems and
investor relations functions and for legal, consulting and accounting fees of
the Company.  The increase of $127 in spending for the three months
ended June 30, 2008 was primarily due to increases in accounting fees and the
calculated bad debt expense estimate offset by decreases in legal fees and stock
based compensation expense (SFAS No.123R).  The decrease in legal fees
is primarily due to the termination of the litigation against AMS, Agilent, and
the Avago Entities.  The underlying matter was settled in December
2006, however additional related litigation over attorneys fees was concluded
January 2008.
 
 Other
income, net
 
 Other income,, net
consists principally of interest income, other income, gains and losses on
foreign exchange and gain and losses on the disposal of fixed
assets.  Total other income, net decreased by $538 in the three months
ended June 30, 2008 over the three months ended June 30, 2007. The majority of
the decrease is related to other income.  In the prior fiscal year we
received $278 related to the AMS settlement.  (Please see the comments
in “Legal Proceedings” above.)  Also in the current period, interest
income decreased by of $177 compared to the prior period.  Net
interest income is lower because of lower cash balances earning lower
interest.
 
 Contractual
Obligation
 
 The
following summarizes our contractual obligations at June 30, 2008, and the
effect such obligations are expected to have on our liquidity and cash flows in
future periods (in thousands).
 
 Contractual
      obligations:
              
              Total
              
              
              Less
      than
                1 Year
              
              
              1-3 Years
              
              
              3-5 Years
              
              
              After
                5 YearsNon-cancelable
      capital lease obligations
              
              $
              10
              
              
              $
              10
              
              
              $
              —
              
              
              $
              —
              
              
              $
              —Non-cancelable
      operating lease obligations
              
              
              799
              
              
              
              544
              
              
              
              238
              
              
              
              17
              
              
              
              —Total
      contractual cash
      obligations
              
              $
              809
              
              
              $
              554
              
              
              $
              238
              
              
              $
              17
              
              
              $
              —
 
 Certain
of our sales contracts include provisions under which customers would be
indemnified by us in the event of, among other things, a third-party claim
against the customer for intellectual property rights infringement related to
our products. There are no limitations on the maximum potential future payments
under these guarantees. We have accrued no amounts in relation to these
provisions as no such claims have been made and we believe we have valid,
enforceable rights to the intellectual property embedded in its
products.
 
 Liquidity
and Capital Resources
 
 For the
three-month period ended June 30, 2008, we financed our operations through the
use of outstanding cash balances.  In fiscal 2008 we financed our
operations through net cash provided by operations.  In fiscal 2007 we
financed our operations through the use of outstanding cash
balances.  We received $19,500 representing the gross cash proceeds
from the settlement of the AMS  litigation.
 
 The
consolidated financial statements contemplate the realization of assets and the
satisfaction of liabilities in the normal course of business. We incurred net
losses of ($792) and ($638) for the three months ended June 30, 2008 and 2007,
respectively. We used cash from operations of ($927) and ($2,325) for the period
ended June 30, 2008 and June 30, 2007, respectively. In fiscal 2008 we financed
our operations through net cash provided by operations and from the release of
$14,705 from litigation suspense related to the settlement of the AMS litigation
(See 7. Legal Proceedings).  In fiscal 2007 we financed our operations
through the use of outstanding cash balances.  Management believes
that these proceeds, combined with projected sales and continued cost
containment will be adequate to fund operations through the next twelve
months.  However, projected sales may not materialize and unforeseen
costs may be incurred.If the projected
sales do not materialize, we will need to reduce expenses further and raise
additional capital through the issuance of debt or equity securities. If
additional funds are raised through the issuance of preferred stock or debt,
these securities could have rights, privileges or preferences senior to those of
common stock, and debt covenants could impose restrictions on our operations.
The sale of equity or debt could result in additional dilution to current
stockholders, and such financing may not be available to us on acceptable terms,
if at all.
 
 - 13
-
 Item
3.  Quantitative and
Qualitative Disclosures About Market Risk
 
 Our cash
equivalents are principally comprised of money market accounts.  As of
June30,
2008, we had cash and cash equivalents of $18,181.  Our
exposure to foreign currency fluctuations is primarily related to sales of our
products in Europe, which are denominated in the Euro. Changes in the exchange
rate between the Euro and the U.S. dollar could adversely affect our operating
results. Exposure to foreign currency exchange rate risk may increase over time
as our business evolves and our products continue to be sold into international
markets. Currently, we do not hedge against any foreign currencies and, as a
result, could incur unanticipated gains or losses.  For the quarter
ended June 30, 2008, fluctuations of the U.S. dollar in relation to the Euro
were immaterial to our financial statements.
 
 Interest
Rate Risk
 
 We are
only marginally exposed to interest rate risk through interest earned on money
market accounts. Interest rates that may affect these items in the future will
depend on market conditions and may differ from the rates we have experienced in
the past. We do not hold or issue derivatives, commodity instruments or other
financial instruments for trading purposes.
  Item
4.   Controls
and Procedures
 
 Evaluation of
disclosure controls and procedures.
  As of the period covered
by this quarterly report, management performed, with the participation of our
Chief Executive Officer and Chief Financial Officer, an evaluation of the
effectiveness of our disclosure controls and procedures as defined in Rule
13a-15(e) and 15d-15(e) of the Exchange Act.  Our disclosure controls
and procedures are designed to ensure that information required to be disclosed
in the report we file or submit under the Exchange Act is recorded, processed,
summarized, and reported within the time periods specified in the rules and
forms of the Securities and Exchange Commission, and that such information is
accumulated and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, as appropriate to allow timely decisions
regarding required disclosures.   Based on the evaluation, our
Chief Executive Officer and Chief Financial Officer concluded that as of June
30, 2008, such disclosure controls and procedures were effective.
 
 Changes
in Internal Control Over Financial Reporting
 
 There were no changes in
our internal control over financial reporting during the quarter ended June 30,
2008 that materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.
  Disclosure
Controls and Internal Controls for Financial Reporting
  Disclosure controls are
procedures that are designed with the objective of ensuring that information
required to be disclosed in our reports filed under the Exchange Act such as
this Quarterly Report on Form 10-Q, is recorded, processed, summarized and
reported within the time periods specified in the SEC’s rules and forms.
Disclosure controls are also designed with the objective of ensuring that such
information is accumulated and communicated to our management, including the
Chief Executive Officer and Principal Financial Officer, as appropriate to allow
timely decisions regarding required disclosure. Internal controls for financial
reporting are procedures which are designed with the objective of providing
reasonable assurance that our transactions are properly authorized, our assets
are safeguarded against unauthorized or improper use and our transactions are
properly recorded and reported, all to permit the preparation of our financial
statements in conformity with U.S. GAAP.
 
 
 PART
II — OTHER INFORMATION
 
 Item
1.A.  Risk
Factors
 
 We
wish to caution you that there are risks and uncertainties that could affect our
business. These risks and uncertainties include, but are not limited to, the
risks described below and elsewhere in this report, particularly in
“Forward-Looking Statements.” The following is not intended to be a complete
discussion of all potential risks or uncertainties, as it is not possible to
predict or identify all risk factors.
 
 The
semiconductor industry is cyclical and may experience periodic downturns that
may negatively affect customer demand for our products and result in losses such
as those experienced in the past.
 
 Our
business depends upon the capital expenditures of semiconductor manufacturers,
which in turn depend on the current and anticipated market demand for ICs. The
semiconductor industry is highly cyclical and historically has experienced
periodic downturns, including the downturn we are currently experiencing, which
often have had a detrimental effect on the semiconductor industry’s demand for
semiconductor capital equipment, including etch and deposition systems
manufactured by us. In response to the current prolonged industry slow-down, we
have initiated a substantial cost containment program and completed a
corporate-wide restructuring to preserve our cash. However, the need for
continued investment in research and development, possible capital equipment
requirements and extensive ongoing customer service and support requirements
worldwide will continue to limit our ability to reduce expenses in response to
the current and any future downturns.  As a result, we may continue to
experience operating losses such as those we have experienced in the past, which
could materially adversely affect us.
 
 Our
competitors have greater financial resources and greater name recognition than
we do and therefore may compete more successfully in the semiconductor capital
equipment industry than we can.
 
 We
believe that to be competitive, we will require significant financial resources
in order to offer a broad range of systems, to maintain customer service and
support centers worldwide and to invest in research and development. Many of our
existing and potential competitors, including Aviza Technology, Inc., OC
Oerlikon Corporation AG, Ulvac Japan, Ltd., and Canon Anelva Technix
Corporation, Applied Materials, Inc., Lam Research Corporation, Novellus,and
Tokyo Electron Limited, have substantially greater financial resources, more
extensive engineering, manufacturing, marketing and customer service and support
capabilities, larger installed bases of current generation etch, deposition and
other production equipment and broader process equipment offerings, as well as
greater name recognition than we do. We cannot assure you that we will be able
to compete successfully against these companies in the United States or
worldwide.
 
 Our
customers are concentrated and therefore the loss of a significant customer may
harm our business.
 
 The
composition of our top five customers changes from year to year, but net system
sales to our top five customers in fiscal 2008 and 2007 accounted for 87.2% and
77.8% respectively, of our total net system sales.  ST
Microelectronics accounted for 57.8% of our total revenue in fiscal
2008.  ST Microelectronics and International Rectifier accounted for
43.1% and 13.4%, respectively, of our total revenue in fiscal
2007.  During the quarter ended June 30, 2008, SVTC Tech LLC and
Diodes Fab Tech Inc. accounted for 37% and 25% respectively, of our total
revenue.  During the quarter ended June 30, 2007, ST Microelectronics
accounted for 68% of total revenues.  Other than these customers, no
single customer represented more than 10% of our total revenue in fiscal 2008 or
the three months ended June 30, 2008.   With the addition of
International Rectifier, no other customers represented more than 10% of our
total revenue in fiscal 2007 or the three months ended June 30,
2007.  Although the composition of the group comprising our largest
customers may vary from year to year, and quarter to quarter, the loss of a
significant customer or any reduction in orders by any significant customer,
including reductions due to market, economic or competitive conditions in the
semiconductor and related device manufacturing industry, would have a material
adverse effect on us.
 
 Our
potential customers may not adopt our products because of their significant cost
or because our potential customers are already using a competitor’s
tool.
 
 A
substantial investment is required to install and integrate capital equipment
into a semiconductor production line. Additionally, we believe that once a
device manufacturer has selected a particular vendor’s capital equipment, that
manufacturer generally relies upon that vendor’s equipment for that specific
production line application and, to the extent possible, subsequent generations
of that vendor’s systems. Accordingly, it may be extremely difficult to achieve
significant sales to a particular customer once that customer has selected
another vendor’s capital equipment unless there are compelling reasons to do so,
such as significant performance or cost advantages. Any failure to gain access
and achieve sales to new customers will adversely affect the successful
commercial adoption of our products and could have a material adverse effect on
us.
 
 - 14
-
 We
depend on sales of our advanced products to customers that may not fully adopt
our product for production use.
 
 We have
designed our advanced etch and deposition products for customer applications in
emerging new films, polysilicon and metal which we believe to be the leading
edge of critical applications for the production of advanced semiconductor and
other microelectronic devices. Revenue from the sale of our advanced etch and
deposition systems accounted for 80% and 69% of total revenue in fiscal 2008 and
2007,, respectively. Our advanced systems are currently being used primarily for
research and development activities or low volume production. For our advanced
systems to achieve full market adoption, our customers must utilize these
systems for volume production. We cannot assure you that the market for devices
incorporating emerging films, polysilicon or metal will develop as quickly or to
the degree we expect.  If our advanced systems do not achieve
significant sales or volume production due to a lack of full customer adoption,
we will be materially adversely affected.
 
 We
have incurred operating losses and may not be profitable in the
future.  Our plans to maintain and increase liquidity may not be
successful.
 
 For the
three months ended June 30, 2008, we incurred a net loss of
($792).  We incurred net income/(losses) of $18.1 million and ($13.2)
million for the years ended March 31, 2008 and 2007,  respectively,
and (used) generated cash flows from operations of ($5.1) million and $12.8
million, in these respective years.  We believe that these proceeds
and the release of the litigation suspense, combined with continued cost
containment will be adequate to fund operations through fiscal year 2009. Our
businesss is dependent upon the sales of our capital equipment, and projected
sales may not materialize and unforeseen costs may be incurred.  If
the projected sales do not materialize, we will need to reduce expenses further
and/or raise additional capital which may include capital raises through the
issuance of debt or equity securities.  If additional funds are raised
through the issuance of preferred stock or debt, these securities could have
rights, privileges or preferences senior to those of our common stock, and debt
covenants could impose restrictions on our operations. Moreover, such financing
may not be available to us on acceptable terms, if at all.  Failure to
raise any needed funds would materially adversely affect us.
 
 Our
quarterly operating results may continue to fluctuate.
 
 Our
revenue and operating results have fluctuated and are likely to continue to
fluctuate significantly from quarter to quarter, and we cannot assure you that
we will achieve profitability in the future.
 
 Our 900
series etch systems typically sell for prices ranging between $250,000 and
$600,000, while prices of our 6500 series critical etch systems and our Endeavor
deposition system typically range between $1.8 million and $3.0 million. To the
extent we are successful in selling our 6500 and Endeavor series systems, the
sale of a small number of these systems will probably account for a substantial
portion of revenue in future quarters, and a transaction for a single system
could have a substantial impact on revenue and gross margin for a given
quarter.
 
 Other
factors that could affect our quarterly operating results include:
 
 ·
              our
      timing of new systems and technology announcements and releases and
      ability to transition between product
versions;
 
 ·
              seasonal
      fluctuations in sales;
 
 ·
              changes
      in the mix of our revenues represented by our various products and
      customers;
 
 ·
              adverse
      changes in the level of economic activity in the United States or other
      major economies in which we do
business;
 
 ·
              foreign
      currency exchange rate
fluctuations;
 
 ·
              expenses
      related to, and the financial impact of, possible acquisitions of other
      businesses; and
 
 ·
              changes
      in the timing of product orders due to unexpected delays in the
      introduction of our customers’ products, due to lifecycles of our
      customers’ products ending earlier than expected or due to market
      acceptance of our customers’
products.
 
 Some
of our sales cycles are lengthy, exposing us to the risks of inventory
obsolescence and fluctuations in operating results.
 
 Sales of
our systems depend, in significant part, upon the decision of a prospective
customer to add new manufacturing capacity or to expand existing manufacturing
capacity, both of which typically involve a significant capital commitment. We
often experience delays in finalizing system sales following initial system
qualification while the customer evaluates and receives approvals for the
purchase of our systems and completes a new or expanded facility. Due to these
and other factors, our systems typically have a lengthy sales cycle (often 12 to
18 months in the case of critical etch and deposition systems) during which we
may expend substantial funds and management effort. Lengthy sales cycles subject
us to a number of significant risks, including inventory obsolescence and
fluctuations in operating results over which we have little or no
control.
 
 Because
technology changes rapidly, we may not be able to introduce our products in a
timely enough fashion.
 
 The
semiconductor manufacturing industry is subject to rapid technological change
and new system introductions and enhancements. We believe that our future
success depends on our ability to continue to enhance our existing systems and
their process capabilities, and to develop and manufacture in a timely manner
new systems with improved process capabilities. We may incur substantial
unanticipated costs to ensure product functionality and reliability early in our
products’ life cycles. We cannot assure you that we will be successful in the
introduction and volume manufacture of new systems or that we will be able to
develop and introduce, in a timely manner, new systems or enhancements to our
existing systems and processes which satisfy customer needs or achieve market
adoption.
 
 Our
financial performance may adversely affect the morale and performance of our
personnel and our ability to hire new personnel.
 
 Our
common stock has declined in value below the exercise price of many options
granted to employees pursuant to our stock option plans. Thus, the intended
benefits of the stock options granted to our employees, the creation of
performance and retention incentives, may not be realized. As a result, we may
lose employees whom we would prefer to retain and may have difficulty in hiring
new employees to replace them. As a result of these factors, our remaining
personnel may seek employment with larger, more established companies or
companies perceived as having less volatile stock prices.  The loss of
any significant employee or a large number of employees over a short period of
time could have a material adverse effect on us.
 
 We
may not be able to protect our intellectual property or obtain licenses for
third parties’ intellectual property and therefore we may be exposed to
liability for infringement or the risk that our operations may be adversely
affected.
 
 Although
we attempt to protect our intellectual property rights through patents,
copyrights, trade secrets and other measures, we may not be able to protect our
technology adequately and competitors may be able to develop similar technology
independently. Additionally, patent applications that we may file may not be
issued and foreign intellectual property laws may not protect our intellectual
property rights. There is also a risk that patents licensed by or issued to us
will be challenged, invalidated or circumvented and that the rights granted
thereunder will not provide competitive advantages to us. Furthermore, others
may independently develop similar systems, duplicate our systems or design
around the patents licensed by or issued to us.
 
 Litigation
to protect our intellectual property could result in substantial cost and
diversion of effort by us, which by itself could have a material adverse effect
on our financial condition, operating results and cash flows. Further, adverse
determinations in such litigation could result in our loss of proprietary
rights, subject us to significant liabilities to third parties, require us to
seek licenses from third parties or prevent us from manufacturing or selling our
systems. In addition, licenses under third parties’ intellectual property rights
may not be available on reasonable terms, if at all.
 
 - 15
-
 We
are exposed to additional risks associated with international sales and
operations.
 
 International
sales accounted for 72%, and 67 of total revenue for fiscal 2008 and 2007,
respectively. For the three months ended June 30, 2008, international sales
accounted for 21.6% of total revenue.  International sales are subject
to certain risks, including the imposition of government controls, fluctuations
in the U.S. dollar (which could increase the sales price in local currencies of
our systems in foreign markets), changes in export license and other regulatory
requirements, tariffs and other market barriers, political and economic
instability, potential hostilities, restrictions on the export or import of
technology, difficulties in accounts receivable collection, difficulties in
managing representatives, difficulties in staffing and managing international
operations and potentially adverse tax consequences. We cannot assure you that
any of these factors will not have a detrimental effect on our operations,
financial results and cash flows.
 
 We cannot
assure you that our future results of operations and cash flows will not be
adversely affected by foreign currency fluctuations. In addition, the laws of
certain countries in which our products are sold may not provide our products
and intellectual property rights with the same degree of protection as the laws
of the United States.
 
 Evolving
regulation of corporate governance and public disclosure may result in
additional expenses and continuing uncertainty.
  Changing
laws, regulations and standards relating to corporate governance and public
disclosure, including the Sarbanes-Oxley Act of 2002, new Securities and
Exchange Commission (“SEC”) regulations and Nasdaq Market rules are creating
uncertainty for public companies. We continually evaluate and monitor
developments with respect to new and proposed rules and cannot predict or
estimate the amount of the additional costs we may incur or the timing of such
costs. These new or changed laws, regulations and standards are subject to
varying interpretations, in many cases due to their lack of specificity, and as
a result, their application in practice may evolve over time as new guidance is
provided by regulatory and governing bodies. This could result in continuing
uncertainty regarding compliance matters and higher costs necessitated by
ongoing revisions to disclosure and governance practices. We are committed to
maintaining high standards of corporate governance and public disclosure. As a
result, we have invested resources to comply with evolving laws, regulations and
standards, and this investment may result in increased general and
administrative expenses and a diversion of management time and attention from
revenue-generating activities to compliance activities. If our efforts to comply
with new or changed laws, regulations and standards differ from the activities
intended by regulatory or governing bodies due to ambiguities related to
practice, regulatory authorities may initiate legal proceedings against us and
we may be materially adversely affected.
 
 Our
stock price is volatile and could result in a material decline in the value of
your investment in Tegal.
 
 We
believe that factors such as announcements of developments related to our
business, fluctuations in our operating results, sales of our common stock into
the marketplace, failure to meet or changes in analysts’ expectations, general
conditions in the semiconductor industry or the worldwide economy, announcements
of technological innovations or new products or enhancements by us or our
competitors, developments in patents or other intellectual property rights,
developments in our relationships with our customers and suppliers, natural
disasters and outbreaks of hostilities could cause the price of our common stock
to fluctuate substantially. In addition, in recent years the stock market in
general, and the market for shares of small capitalization stocks in particular,
have experienced extreme price fluctuations, which have often been unrelated to
the operating performance of affected companies. We cannot assure you that the
market price of our common stock will not experience significant fluctuations in
the future, including fluctuations that are unrelated to our
performance.
 
 The
exercise of outstanding warrants, options and other rights to obtain additional
shares will dilute the value of our shares of common stock and could cause the
price of our shares of common stock to decline.
 
 As of
June 30, 2008, there were 7,263,473 shares of our common stock issued and
outstanding, 3,431,593 shares of our common stock reserved for issuance of
shares issuable upon exercise of outstanding warrants, and shares underlying
equity awards created or available for grant under our equity incentive plans,
and shares available under our stock purchase plan.
 
 The
exercise of these warrants and options and the issuance of the common stock
pursuant to our equity incentive plans will result in dilution in the value of
the shares of our outstanding common stock and the voting power represented
thereby. In addition, the exercise price of the warrants may be lowered under
the price adjustment provisions in the event of a “dilutive issuance,” that is,
if we issue common stock at any time prior to their maturity at a per share
price below such conversion or exercise price, either directly or in connection
with the issuance of securities that are convertible into, or exercisable for,
shares of our common stock. A reduction in the exercise price may result in the
issuance of a significant number of additional shares upon the exercise of the
warrants.
 
 The
outstanding warrants do not establish a “floor” that would limit reductions in
such conversion price or exercise price.  The downward adjustment of
the exercise price of these warrants could result in further dilution in the
value of the shares of our outstanding common stock and the voting power
represented thereby.
 
 No
prediction can be made as to the effect, if any, that future sales of shares of
our common stock, or the availability of shares for future sale, will have on
the market price of our common stock prevailing from time to time. Sales of
substantial amounts of shares of our common stock in the public market, or the
perception that such sales could occur, may adversely affect the market price of
our common stock and may make it more difficult for us to sell our equity
securities in the future at a time and price which we deem
appropriate.
 
 To the
extent our stockholders and the other holders of our warrants and options
exercise such securities and then sell the shares of our common stock they
receive upon exercise, our stock price may decrease due to the additional amount
of shares available in the market. The subsequent sales of these shares could
encourage short sales by our securityholders and others, which could place
further downward pressure on our stock price. Moreover, holders of these
warrants and options may hedge their positions in our common stock by shorting
our common stock, which could further adversely affect our stock
price.
 
 Potential
disruption of our supply of materials required to build our systems could have a
negative effect on our operations and damage our customer
relationships.
 
 Materials
delays have not been significant in recent years. Nevertheless, we procure
certain components and sub-assemblies included in our systems from a limited
group of suppliers, and occasionally from a single source supplier. Such
components and assemblies include robots, electro-static chucks, power supplies
and flow control devices.  Disruption or termination of certain of
these sources could have an adverse effect on our operations and damage our
relationship with our customers.
 
 Any
failure by us to comply with environmental regulations imposed on us could
subject us to future liabilities.
 
 We are
subject to a variety of governmental regulations related to the use, storage,
handling, discharge or disposal of toxic, volatile or otherwise hazardous
chemicals used in our manufacturing process. We believe that we are currently in
compliance in all material respects with these regulations and that we have
obtained all necessary environmental permits generally relating to the discharge
of hazardous wastes to conduct our business. Nevertheless, our failure to comply
with present or future regulations could result in additional or corrective
operating costs, suspension of production, alteration of our manufacturing
processes or cessation of our operations.
  Item
6.   Exhibits
 
  ExhibitNumber
              Description
 
 31.1
              Certifications
      of the Chief Executive Officer pursuant to Section 302 of the
      Sarbanes-Oxley Act of 2002.31.2
              Certifications
      of the Chief Financial Officer pursuant to Section 302 of the
      Sarbanes-Oxley Act of 2002.32
              Certifications
      of the Chief Executive Officer and Chief Financial Officer pursuant to
      Section 906 of the Sarbanes-Oxley Act of
2002.
  - 16
-
  SIGNATURES
 
 Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
 
 TEGAL
      CORPORATION
                (Registrant)/s/  CHRISTINE
      HERGENROTHER
                Christine
      Hergenrother
                Chief
      Financial OfficerDated:
      August 14 , 2008
  - 17
-
  
 
 EXHIBIT
31.1
 
 CERTIFICATION
OF THE CHIEF EXECUTIVE OFFICER
 PURSUANT
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
 I, Thomas
R. Mika, certify that:
 
 1.
              I
      have reviewed this quarterly report on Form 10-Q of Tegal
      Corporation;
 
 2.
              Based
      on my knowledge, this report does not contain any untrue statement of a
      material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      report;
 
 3.
              Based
      on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this
      report;
 
 4.
              The
      registrant’s other certifying officer and I am responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-14(e)) for the registrant
      and we have:
 
 (a) Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
 
 (b) Designed
such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
 
 (c) Evaluated
the effectiveness of the registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
 
 (d) Disclosed
in this report any change in the registrant’s internal control over financial
reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial reporting; and
 
 5.
              The
      registrant’s other certifying officer and I have disclosed, based on our
      most recent evaluation of internal control over financial reporting, to
      the registrant’s auditors and the audit committee of the registrant’s
      board of directors (or persons performing the equivalent
      function):
 
 (a)
              all
      significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the registrant’s ability to record,
      process, summarize and report financial information;
  and
 
 (b)
              any
      fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant’s internal
      controls over financial reporting.
 
  /s/   Thomas
R.
Mika
 Chief
Executive Officer and President
    - 18
-
  
 EXHIBIT
31.2
 
 CERTIFICATION
OF THE CHIEF FINANCIAL OFFICER
 PURSUANT
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
 I,
Christine Hergenrother, certify that:
 
 1.
              I
      have reviewed this quarterly report on Form 10-Q of Tegal
      Corporation;
 
 2.
              Based
      on my knowledge, this report does not contain any untrue statement of a
      material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      report;
 
 3.
              Based
      on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this
      report;
 
 4.
              The
      registrant’s other certifying officer and I am responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-14(e)) for the registrant
      and we have:
 
 (a) Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
 
 (b) Designed
such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
 
 (c) Evaluated
the effectiveness of the registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
 
 (d) Disclosed
in this report any change in the registrant’s internal control over financial
reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial reporting; and
 
 5.
              The
      registrant’s other certifying officer and I have disclosed, based on our
      most recent evaluation of internal control over financial reporting, to
      the registrant’s auditors and the audit committee of the registrant’s
      board of directors (or persons performing the equivalent
      function):
 
 (a)
              all
      significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the registrant’s ability to record,
      process, summarize and report financial information;
  and
 
 (b)
              any
      fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant’s internal
      controls over financial reporting.
  
 /s/  Christine
Hergenrother
 Chief
Financial Officer
  
 
 
 - 19
-
 
 
 EXHIBIT
32
 
 CERTIFICATION
PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 (18
U.S.C. SECTION 1350)
  In connection with the Quarterly Report
of Tegal Corporation, a Delaware corporation (the “Company”), on Form 10-Q for
the quarter ended June 30, 2008 as filed with the Securities and Exchange
Commission (the “Report”), I, Thomas R. Mika, President and Chief Executive
Officer of the Company, certify, pursuant to § 906 of the Sarbanes-Oxley Act of
2002 (18 U.S.C. § 1350), that to my knowledge:
  (1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
  (2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.
   
 /s/   Thomas
R.
Mika
 Chief
Executive Officer and President
 August
14, 2008
  
 
 CERTIFICATION
PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 (18
U.S.C. SECTION 1350)
  In connection with the Quarterly Report
of Tegal Corporation, a Delaware corporation (the “Company”), on Form 10-Q for
the quarter ended June 30, 2008 as filed with the Securities and Exchange
Commission (the “Report”), I, Christine Hergenrother, Chief Financial Officer of
the Company, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18
U.S.C. § 1350), that to my knowledge:
  (1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
  (2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.
  
 /s/   Christine
Hergenrother
 Chief
Financial Officer
 August
14, 2008